ARCHIVES

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

This article is from The Cancer Letter archive.

Vol. 27 No. 27 | July 6, 2001

Download PDF Visit The Full Archive

Related Articles

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004

RFA For Patterns Of Care Study in Elderly Issues

January 14, 1983

NCI To Slow New Center Development To Assure Funding For Existing Commitments, King Says

February 14, 1975

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

Funding Opportunities

April 26, 2002

Also Cancer policy board urges NCI to convene panel on long-term care for childhood cancer survivors.

October 10, 2003